Overview Fundamentals API Earnings EOD API Sample Code Pricing

BiomX Inc (PHGEW PINK) stock market data APIs

$0.0012 0(0%) as of July 26, 2024
Price chart is built with Anychart

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

BiomX Inc Financial Data Overview

0.0012
0.0012
-
0.0012
0.0012
0.0002-0.0189
0
0
0
1.312
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PHGEW',
Type: 'Common Stock',
Name: 'BiomX Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00NHN2G93',
ISIN: NULL,
CUSIP: NULL,
CIK: '1739174',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

BiomX Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -24 307 000
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get BiomX Inc Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get BiomX Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com